Skip to main content
INOVIO PHARMACEUTICALS, INC. logo

INOVIO PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · INO ISIN · US45773H4092 LEI · 529900B9W875XDZXTM97 US Manufacturing
Filings indexed 1,000 across all filing types
Latest filing 2026-04-06 Regulatory Filings
Country US United States of America
Listing US INO

About INOVIO PHARMACEUTICALS, INC.

https://www.inovio.com/

INOVIO PHARMACEUTICALS, INC. is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines. The company's core technology centers on designing proprietary DNA plasmids—small, circular DNA molecules that instruct the body's cells to produce specific, targeted proteins to combat disease. These DNA medicines are delivered into cells using the company's proprietary investigational CELLECTRA® smart devices. This platform is designed to enable in vivo protein production and achieve therapeutic effect without the use of chemical adjuvants, lipid nanoparticles, or viral vectors. The company's development pipeline targets HPV-related diseases, various cancers, and infectious diseases.

Recent filings

Filing Released Lang Actions
8-K - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Regulatory Filings
2026-04-06 English
8-K - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Regulatory Filings
2026-04-02 English
4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Director's Dealing
2026-02-27 English
4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Director's Dealing
2026-02-27 English
4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Director's Dealing
2026-02-27 English
4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Director's Dealing
2026-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.